PLoS Clin Trials. 2006 Dec 22;1(8):e41.

The suspension of treatments in ADAPT: concerns beyond the cardiovascular safety of celecoxib or naproxen.

Breitner JC, Martin BK, Meinert CL.

Comment on

PLoS Clin Trials. 2006;1(7):e35.

PMID:: 17192795; [PubMed]
PMCID: PMC1713263

Free PMC Article

Publication Types

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

ClinicalTrials.gov

Supplemental Content

Related citations

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. [Am Heart J. 2009]
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
Becker MC, Wang TH, Wisniewski L, Wolski K, Libby P, Lüscher TF, Borer JS, Mascette AM, Husni ME, Solomon DH, et al. Am Heart J. 2009 Apr; 157(4):606-12. Epub 2009 Feb 25.
A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis. [J Rheumatol. 2009]
A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis.
Foeldvari I, Szer IS, Zemel LS, Lovell DJ, Giannini EH, Robbins JL, West CR, Steidle G, Krishnaswami S, Bloom BJ. J Rheumatol. 2009 Jan; 36(1):174-82.
Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults. [Clin Ther. 2006]
Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF, Hsiao FY, Wen YW, Tsai YW. Clin Ther. 2006 Nov; 28(11):1827-36.
Review The safety of celecoxib in ankylosing spondylitis treatment. [Expert Opin Drug Saf. 2008]
Review The safety of celecoxib in ankylosing spondylitis treatment.
Poddubnyy DA, Song IH, Sieper J. Expert Opin Drug Saf. 2008 Jul; 7(4):401-9.
Review Pharmacological treatment of heterotopic ossification following hip and acetabular surgery. [Expert Opin Pharmacother. 2008]
Review Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
Macfarlane RJ, Ng BH, Gamie Z, El Masry MA, Velonis S, Schizas C, Tsiridis E. Expert Opin Pharmacother. 2008 Apr; 9(5):767-86.

See reviews... See all...

Cited by 3 PubMed Central articles

Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. [Clin Trials. 2009]
Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.
Lee J, Andriole G, Avins A, Crawford ED, Foster H, Kaplan S, Kreder K, Kusek J, McCullough A, McVary K, et al. Clin Trials. 2009 Dec; 6(6):628-36. Epub 2009 Dec 9.
Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results. [Alzheimers Dement. 2009]
Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results.
ADAPT Research Group, Meinert CL, McCaffrey LD, Breitner JC. Alzheimers Dement. 2009 Mar; 5(2):93-104.
Review Therapeutic targets in prostaglandin E2 signaling for neurologic disease. [Curr Med Chem. 2008]
Review Therapeutic targets in prostaglandin E2 signaling for neurologic disease.
Cimino PJ, Keene CD, Breyer RM, Montine KS, Montine TJ. Curr Med Chem. 2008; 15(19):1863-9.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The suspension of treatments in ADAPT: concerns beyond the cardiovascular safety...
The suspension of treatments in ADAPT: concerns beyond the cardiovascular safety of celecoxib or naproxen.
PLoS Clin Trials. 2006 Dec 22 ;1(8):e41.

PubMed
Venezuelan kindreds reveal that genetic and environmental factors modulate Hunti...
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.
Proc Natl Acad Sci U S A. 2004 Mar 9 ;101(10):3498-503. Epub 2004 Mar 1 .

PubMed
Multiple aromatic side chains within a disordered structure are critical for tra...
Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins.
Proc Natl Acad Sci U S A. 2007 Jan 9 ;104(2):479-84. Epub 2007 Jan 3 .

PubMed
HIV medication adherence programs: the importance of social support.
HIV medication adherence programs: the importance of social support.
J Community Health Nurs. 2004 Summer ;21(2):111-22.

PubMed
Genome-wide strategies for detecting multiple loci that influence complex diseas...
Genome-wide strategies for detecting multiple loci that influence complex diseases.
Nat Genet. 2005 Apr ;37(4):413-7. Epub 2005 Mar 27 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

The suspension of treatments in ADAPT: concerns beyond the cardiovascular safety of celecoxib or naproxen.

Comment on

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Related citations

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information